110958-19-5 Usage
Description
Fasoracetam, a synthetic compound within the racetam family, is recognized for its nootropic properties, which are cognitive enhancers. It is primarily utilized as a study aid to improve memory and learning capabilities. Fasoracetam modulates neurotransmitter activity in the brain, with a particular focus on the glutamate and GABA systems, and is considered a promising candidate for treating conditions such as ADHD and anxiety. Preliminary research indicates its potential in neuroprotection and antidepressant effects, although further studies are necessary to confirm these findings. When used at appropriate doses, fasoracetam is deemed safe and well-tolerated.
Uses
Used in Pharmaceutical Industry:
Fasoracetam is used as a cognitive enhancer for improving memory and learning, which makes it a valuable asset in the development of nootropic drugs aimed at enhancing cognitive functions.
Used in Neurological Treatment:
Fasoracetam is used as a potential treatment for conditions such as ADHD and anxiety due to its effects on neurotransmitter systems in the brain.
Used in Research and Development:
Fasoracetam is used in scientific research for exploring its neuroprotective and antidepressant effects, indicating its potential use in the development of treatments for neurodegenerative diseases and mood disorders.
Used in Nutraceutical Industry:
As a dietary supplement, fasoracetam is used to support cognitive health and enhance brain function, making it a popular choice among individuals seeking to improve their mental performance.
Check Digit Verification of cas no
The CAS Registry Mumber 110958-19-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,9,5 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 110958-19:
(8*1)+(7*1)+(6*0)+(5*9)+(4*5)+(3*8)+(2*1)+(1*9)=115
115 % 10 = 5
So 110958-19-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H16N2O2/c13-9-5-4-8(11-9)10(14)12-6-2-1-3-7-12/h8H,1-7H2,(H,11,13)/t8-/m1/s1
110958-19-5Relevant articles and documents
SOLID FORMS OF FASORACETAM
-
Paragraph 00741; 00742, (2019/08/08)
The disclosure is directed to cocrystals of fasoracetam, including R-fasoracetam, and various coformers. Crystalline materials comprising fasoracetam, including R-fasoracetam, are also provided. The disclosure further includes pharmaceutical compositions and methods of treatment of the cocrystals and crystalline materials of the disclosure.
Synthesis of chiral diamines using novel 2-trichloromethyloxazolidin-4-one precursors derived from 5-oxo-proline and proline
Amedjkouh, Mohamed,Ahlberg, Per
, p. 2229 - 2234 (2007/10/03)
Efficient syntheses of chiral vicinal diamines derived from (S)-oxo-proline and (S)-proline are described. The novel diastereomerically pure precursor (2R,5S)-2-trichloromethyl-1-aza-3-oxabicyclo-[3.3.0]-octan-4,8-dione 3 and its enantiomer are readily available by reaction of the inexpensive enantiomers of 5-oxo-proline with chloral. Compound 3 reacts with primary and secondary amines to afford the 5-oxo-prolylamides 4 in quantitative yield. In contrast, the (S)-proline-derived precursor (2R,5S)-2-trichloromethyl-1-aza-3-oxabicyclo[3.3.0]octan-4-one 6 gave (S)-N-formylprolylamides 9 and/or (S)-prolylamides 8 depending on the reaction conditions. Upon reduction with LiAlH4, amides 4 and 9 afforded the proline-derived (S)-2-(alkylaminomethyl)pyrrolidines 1 and (S)-N-methyl-2-(alkylaminomethyl)-pyrrolidines 5 in 70-90% yields.